Literature DB >> 2896594

Differential effects of timolol and metoprolol on platelet function at rest and during exercise.

K Winther1, J B Knudsen, E O Jørgensen, E Eldrup.   

Abstract

Ten male patients suffering from stable angina pectoris were studied at rest and immediately after exercise during treatment either with timolol (a non-selective beta-blocker) or with metoprolol (a beta 1-selective blocker). Timolol induced a significant increase in platelet aggregation and a reduction in platelet cyclic AMP, and it also raised the plasma adrenaline at rest and during exercise as compared to the pre-treatment level. Metoprolol had none of these effects. Prior to medication and during metoprolol treatment, exercise led to an increase in the peripheral platelet count, whereas timolol was associated with a reduction of platelets during physical effort. Neither drug affected platelet thromboxane B2 at rest. During exercise, its level was not affected in the pre-treatment period or during metoprolol treatment but it was sharply increased by timolol therapy.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2896594     DOI: 10.1007/bf00542492

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  20 in total

1.  Aggregation of blood platelets by adenosine diphosphate and its reversal.

Authors:  G V BORN
Journal:  Nature       Date:  1962-06-09       Impact factor: 49.962

2.  Arachidonic acid metabolites and the interactions between platelets and blood-vessel walls.

Authors:  S Moncada; J R Vane
Journal:  N Engl J Med       Date:  1979-05-17       Impact factor: 91.245

3.  Characterization of alpha- and beta-adrenergic receptors linked to human platelet adenylate cyclase.

Authors:  K H Jakobs; W Saur; G Schultz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-05       Impact factor: 3.000

4.  The use of non-parametric methods in the statistical analysis of the two-period change-over design.

Authors:  G G Koch
Journal:  Biometrics       Date:  1972-06       Impact factor: 2.571

5.  The difference between non-selective and beta 1-selective beta-blockers in their effect on platelet function in migraine patients.

Authors:  C Hedman; K Winther; J B Knudsen
Journal:  Acta Neurol Scand       Date:  1986-12       Impact factor: 3.209

6.  Characterization of human platelet beta-adrenoceptors.

Authors:  K Winther; R Klysner; A Geisler; P H Andersen
Journal:  Thromb Res       Date:  1985-12-15       Impact factor: 3.944

7.  Increased occurrence of left ventricular thrombi during early treatment with timolol in patients with acute myocardial infarction.

Authors:  K A Johannessen; J E Nordrehaug; G von der Lippe
Journal:  Circulation       Date:  1987-01       Impact factor: 29.690

8.  Beta-adrenoceptor antagonists and human platelets: relationship of effects to lipid solubility.

Authors:  R Kerry; M C Scrutton; R B Wallis
Journal:  Biochem Pharmacol       Date:  1984-08-15       Impact factor: 5.858

9.  Long-term treatment with metoprolol after myocardial infarction: effect on 3 year mortality and morbidity.

Authors:  G Olsson; N Rehnqvist; A Sjögren; L Erhardt; T Lundman
Journal:  J Am Coll Cardiol       Date:  1985-06       Impact factor: 24.094

10.  Effects of thromboxane synthetase inhibition on arachidonate metabolism and platelet behaviour.

Authors:  M J Parry
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

View more
  4 in total

1.  Effects of three beta-blockers with different pharmacodynamic properties on platelet aggregation and platelet and plasma cyclic AMP.

Authors:  K Winther; J Trap-Jensen
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

2.  Effect of felodipine, a new calcium channel antagonist, on platelet function and fibrinolytic activity at rest and after exercise.

Authors:  H Sengeløv; K Winther
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

3.  Metoprolol does not reduce platelet aggregability during sympatho-adrenal stimulation.

Authors:  P T Larsson; G Olsson; B Angelin; E Granström; G Hansson; P Hjemdahl
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

4.  Lack of significant effect of therapeutic propranolol on measurable platelet function in healthy subjects.

Authors:  D H Pamphilon; R J Boon; A G Prentice; A Rozkovec
Journal:  J Clin Pathol       Date:  1989-08       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.